Key Points
- Canopy Growth director Theresa Yanofsky sold 14,920 shares at an average price of $0.93, generating $13,875.60 and reducing her ownership by 10.19% to 131,495 shares.
- CGC recently reported quarterly revenue of $142.62 million and an adjusted loss of $0.02 per share, beating analyst estimates, but remains unprofitable with a negative net margin of 65.33%.
- Analysts maintain a consensus “Hold” rating; CGC recently traded near $0.90, compared with a 52-week range of $0.84 to $2.38, while institutional investors own only 3.33% of the stock.
Canopy Growth Corporation (NASDAQ:CGC - Get Free Report) Director Theresa Yanofsky sold 14,920 shares of Canopy Growth stock in a transaction on Monday, September 28th. The shares were sold at an average price of $0.93, for a total transaction of $13,875.60. Following the completion of the sale, the director directly owned 131,495 shares of the company's stock, valued at approximately $122,290.35. This trade represents a 10.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Canopy Growth Price Performance
CGC stock opened at $0.90 on Thursday. The stock has a market capitalization of $402.66 million, a PE ratio of -1.99 and a beta of 0.83. The company's 50-day moving average is $0.96 and its 200-day moving average is $1.00. The company has a debt-to-equity ratio of 0.31, a current ratio of 3.04 and a quick ratio of 2.39. Canopy Growth Corporation has a 1 year low of $0.84 and a 1 year high of $2.38.
Canopy Growth (NASDAQ:CGC - Get Free Report) last issued its earnings results on Friday, August 7th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.02. Canopy Growth had a negative return on equity of 21.91% and a negative net margin of 65.33%.The company had revenue of $142.62 million during the quarter, compared to the consensus estimate of $58.21 million. Equities research analysts expect that Canopy Growth Corporation will post -0.1 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research firms have recently commented on CGC. Wall Street Zen upgraded Canopy Growth from a "sell" rating to a "hold" rating in a report on Saturday, September 26th. Weiss Ratings cut Canopy Growth from a "sell (d-)" rating to a "sell (e+)" rating in a report on Wednesday, September 16th. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of "Hold".
Get Our Latest Stock Analysis on CGC
Institutional Investors Weigh In On Canopy Growth
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd lifted its position in Canopy Growth by 723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,595,330 shares of the company's stock valued at $5,239,000 after acquiring an additional 4,037,281 shares in the last quarter. Lazard Asset Management LLC bought a new stake in Canopy Growth during the 1st quarter worth approximately $1,716,000. Royal Bank of Canada increased its holdings in Canopy Growth by 1,115.6% during the 1st quarter. Royal Bank of Canada now owns 975,967 shares of the company's stock worth $927,000 after purchasing an additional 895,680 shares in the last quarter. Finally, Foundations Investment Advisors LLC bought a new stake in Canopy Growth during the 4th quarter worth approximately $485,000. 3.33% of the stock is owned by institutional investors.
Canopy Growth News Roundup
Here are the key news stories impacting Canopy Growth this week:
- Positive Sentiment: Canopy Growth is reportedly approaching positive EBITDA, suggesting continued progress in reducing losses and improving operating fundamentals. If sustained, a move toward positive EBITDA could strengthen the investment case and support a higher valuation. Canopy Growth Is Closing in on Positive EBITDA. Should You Buy the Stock?
- Neutral Sentiment: Analysts maintain a consensus rating of “Hold,” indicating limited conviction that near-term upside will outweigh the company’s risks. The rating may restrain enthusiasm unless Canopy delivers stronger profitability or growth results. Canopy Growth Receives Consensus Hold Rating
- Neutral Sentiment: Increased investor searches for Canopy Growth reflect heightened market attention, but the report provides no new fundamental or financial catalyst. The added visibility could increase trading activity without establishing a clear direction. Investors Heavily Search Canopy Growth
- Negative Sentiment: Three directors sold CGC shares at approximately $0.93. M. Atkins and Joseph Bayern each sold 3,096 shares, while Theresa Yanofsky sold 14,920 shares—reducing her position by about 10%. Although the transactions were relatively small, multiple insider sales can weigh on sentiment because they suggest limited near-term insider conviction. M. Atkins Insider Sale Joseph Bayern Insider Sale Theresa Yanofsky Insider Sale
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation is a cannabis company headquartered in Smiths Falls, Ontario, Canada. Founded in 2013 as Tweed Marijuana Inc, the company adopted the Canopy Growth name in 2015 and has developed a portfolio of cannabis brands serving both adult-use and medical markets.
Canopy Growth's products include dried cannabis flower, pre-rolls, cannabis oils, softgels, edibles, beverages and vaporization products. Its brand portfolio has included Tweed, 7ACRES, Doja, Deep Space and other cannabis brands, as well as Storz & Bickel vaporization products.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
